title: Novel strategies to combat bacterial virulence.
abstract: OBJECTIVE
  Incidences of antimicrobial-resistant infections have increased dramatically over the past several decades and are associated with adverse patient outcomes. Alternative approaches to combat infection are critical and have led to the development of more specific drugs targeted at particular bacterial virulence systems or essential regulatory pathways. The purpose of this review is to highlight the recent developments in antibacterial therapy and the novel approaches toward increasing our therapeutic armory against bacterial infection.
  
  
  RESULTS
  Although classic antibiotic development is not occurring rapidly, alternative therapeutics that target specific bacterial virulence systems are progressing from the discovery stage through the Food and Drug Administration approval process. Here we review novel antibodies that target specific virulence systems as well as a variety of newly discovered small molecules that block bacterial attachment, communication systems (quorum sensing) or important regulatory processes associated with virulence gene expression.
  
  
  CONCLUSIONS
  The success of novel therapeutics could significantly change clinical practice. Furthermore, the complications of collateral damage due to antibiotic administration, for example, suprainfections or decreased host immunity due to loss of synergistic bacterial communities, may be minimized using therapeutics that specifically target pathogenic behavior.
authors.affiliation: Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, California 94143, USA. lynchs@anesthesia.ucsf.edu
authors.forename: Susan V
authors.initials: SV
authors.lastname: Lynch
authors.forename: Jeanine P
authors.initials: JP
authors.lastname: Wiener-Kronish
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D003422:Critical Care; D024881:Drug Resistance, Bacterial / Q000187:drug effects / Q000235:genetics; D006801:Humans; D053038:Quorum Sensing / Q000187:drug effects; D014774:Virulence
chemical_list: D000900:Anti-Bacterial Agents
references.citation: Curr Opin Microbiol. 2000 Feb;3(1):65-72
references.pmid: 10679419
references.citation: Nature. 2006 Dec 21;444(7122):1022-3
references.pmid: 17183309
references.citation: Microbiology (Reading). 2001 Dec;147(Pt 12):3249-62
references.pmid: 11739757
references.citation: Microbiology (Reading). 2005 Dec;151(Pt 12):3873-3880
references.pmid: 16339933
references.citation: J Clin Microbiol. 2007 Jun;45(6):1954-62
references.pmid: 17409203
references.citation: Burns. 2005 Mar;31(2):153-8
references.pmid: 15683685
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20529-33
references.pmid: 18077362
references.citation: Microbiology (Reading). 2001 Sep;147(Pt 9):2517-2528
references.pmid: 11535791
references.citation: Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2771-6
references.pmid: 12601166
references.citation: Biochim Biophys Acta. 2006 Apr;1760(4):527-37
references.pmid: 16564136
references.citation: Chembiochem. 2001 Dec 3;2(12):915-8
references.pmid: 11948880
references.citation: J Clin Invest. 1999 Sep;104(6):743-50
references.pmid: 10491409
references.citation: Nature. 2006 Dec 21;444(7122):1027-31
references.pmid: 17183312
references.citation: Am J Health Syst Pharm. 2008 Apr 15;65(8):705-15
references.pmid: 18387898
references.citation: Infect Immun. 2000 May;68(5):2916-24
references.pmid: 10768989
references.citation: J Clin Invest. 2007 Apr;117(4):877-88
references.pmid: 17364024
references.citation: Nat Med. 1999 Apr;5(4):392-8
references.pmid: 10202927
references.citation: EMBO J. 2000 Jun 15;19(12):2803-12
references.pmid: 10856226
references.citation: Mol Pharmacol. 2008 May;73(5):1578-86
references.pmid: 18314496
references.citation: Nat Struct Mol Biol. 2004 Jan;11(1):60-6
references.pmid: 14718924
references.citation: J Infect Dis. 2001 Jun 15;183(12):1767-74
references.pmid: 11372029
references.citation: J Infect Dis. 2002 Jul 1;186(1):64-73
references.pmid: 12089663
references.citation: J Antimicrob Chemother. 2004 Jun;53(6):1054-61
references.pmid: 15117922
references.citation: Mol Microbiol. 1997 Mar;23(5):861-7
references.pmid: 9076724
references.citation: Nature. 2002 Jul 25;418(6896):386
references.pmid: 12140548
references.citation: Eur Respir J. 2007 May;29(5):965-8
references.pmid: 17301098
references.citation: Nat Struct Mol Biol. 2004 Jan;11(1):67-72
references.pmid: 14718925
references.citation: Org Biomol Chem. 2007 Jun 21;5(12):1827-34
references.pmid: 17551629
references.citation: Mol Microbiol. 2007 Sep;65(5):1311-20
references.pmid: 17697254
references.citation: Vaccine. 2008 Mar 20;26(13):1616-25
references.pmid: 18304706
references.citation: Antimicrob Agents Chemother. 2007 Jul;51(7):2403-11
references.pmid: 17485504
references.citation: Mol Microbiol. 1999 Sep;33(6):1254-66
references.pmid: 10510239
references.citation: Infect Immun. 1980 May;28(2):546-56
references.pmid: 6772562
references.citation: PLoS Pathog. 2007 Dec;3(12):e196
references.pmid: 18159943
references.citation: J Immune Based Ther Vaccines. 2003 Aug 13;1(1):2
references.pmid: 12943554
references.citation: PLoS Med. 2007 Dec;4(12):e349
references.pmid: 18092887
references.citation: Infect Immun. 1997 Oct;65(10):4199-206
references.pmid: 9317027
references.citation: Infect Immun. 1987 Feb;55(2):472-6
references.pmid: 3542836
references.citation: EMBO J. 2003 Aug 1;22(15):3803-15
references.pmid: 12881415
references.citation: J Bacteriol. 2007 Mar;189(6):2203-9
references.pmid: 17209027
references.citation: J Med Microbiol. 2006 Jun;55(Pt 6):669-675
references.pmid: 16687583
references.citation: Anaerobe. 2005 Oct;11(5):247-51
references.pmid: 16701579
references.citation: Mol Microbiol. 1996 Mar;19(5):1107-16
references.pmid: 8830267
references.citation: Microbiology (Reading). 2007 Jul;153(Pt 7):2363-2372
references.pmid: 17600080
references.citation: Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11070-5
references.pmid: 16033867
references.citation: J Bacteriol. 2007 Jul;189(14):5383-6
references.pmid: 17496081
references.citation: Mol Microbiol. 1997 Aug;25(3):547-57
references.pmid: 9302017
references.citation: Crit Care Med. 2004 Nov;32(11):2293-9
references.pmid: 15640644
references.citation: Adv Drug Deliv Rev. 2002 Dec 5;54(11):1425-43
references.pmid: 12458153
references.citation: Dev Cell. 2002 Oct;3(4):593-603
references.pmid: 12408810
references.citation: J Nutr. 2005 Oct;135(10):2445-8
references.pmid: 16177210
references.citation: Science. 2005 Oct 28;310(5748):670-4
references.pmid: 16223984
references.citation: Can J Microbiol. 1996 May;42(5):479-86
references.pmid: 8640607
references.citation: Infect Immun. 2003 Jul;71(7):3673-81
references.pmid: 12819047
references.citation: Mol Microbiol. 2007 May;64(4):968-83
references.pmid: 17501921
references.citation: Environ Microbiol. 2002 Jan;4(1):18-28
references.pmid: 11966822
references.citation: Mol Microbiol. 2006 Aug;61(3):782-94
references.pmid: 16803594
references.citation: Cell Microbiol. 2007 Sep;9(9):2230-41
references.pmid: 17490405
references.citation: Infect Immun. 2007 Jan;75(1):52-60
references.pmid: 17074856
references.citation: Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17897-902
references.pmid: 17098869
references.citation: Microbiology (Reading). 2005 May;151(Pt 5):1325-1340
references.pmid: 15870443
references.citation: Science. 2005 Jun 10;308(5728):1635-8
references.pmid: 15831718
references.citation: Infect Immun. 2005 May;73(5):3104-14
references.pmid: 15845518
references.citation: J Med Chem. 2005 Feb 24;48(4):935-45
references.pmid: 15715464